These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7914453)
1. Paclitaxel: a new antimitotic chemotherapeutic agent. Gotaskie GE; Andreassi BF Cancer Pract; 1994; 2(1):27-33. PubMed ID: 7914453 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer. Gregory RE; DeLisa AF Clin Pharm; 1993 Jun; 12(6):401-15. PubMed ID: 7691462 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacological action of paclitaxel]. Potemski P; Płuzańska A Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel (Taxol) in breast cancer. Arbuck SG; Dorr A; Friedman MA Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664 [TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies]. Yamazaki S; Sekine I; Saijo N Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372 [TBL] [Abstract][Full Text] [Related]
6. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck. Forastiere AA Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel (Taxol) for the treatment of head and neck cancer. Forastiere AA Semin Oncol; 1994 Oct; 21(5 Suppl 8):49-52. PubMed ID: 7939763 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview. Hájek R; Vorlicek J; Slavik M Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500 [TBL] [Abstract][Full Text] [Related]
9. Taxol: a new and effective anti-cancer drug. Slichenmyer WJ; Von Hoff DD Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876 [TBL] [Abstract][Full Text] [Related]
12. Taxol: a promising new drug of the '90s. Rogers BB Oncol Nurs Forum; 1993; 20(10):1483-9. PubMed ID: 7904060 [TBL] [Abstract][Full Text] [Related]
13. [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes]. Chazard M; Pellae-Cosset B; Garet F; Soares JA; Lucidi B; Lavail Y; Lenaz L Bull Cancer; 1994 Mar; 81(3):173-81. PubMed ID: 7894125 [TBL] [Abstract][Full Text] [Related]
14. Protein nanoparticles as drug carriers in clinical medicine. Hawkins MJ; Soon-Shiong P; Desai N Adv Drug Deliv Rev; 2008 May; 60(8):876-85. PubMed ID: 18423779 [TBL] [Abstract][Full Text] [Related]
15. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Foa R; Norton L; Seidman AD Int J Clin Lab Res; 1994; 24(1):6-14. PubMed ID: 7910054 [TBL] [Abstract][Full Text] [Related]
16. [Paclitaxel (Taxol)]. Hájek R Cas Lek Cesk; 1996 Jun; 135(12):393-6. PubMed ID: 8706079 [TBL] [Abstract][Full Text] [Related]
18. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Wall ME; Wani MC Cancer Res; 1995 Feb; 55(4):753-60. PubMed ID: 7850785 [TBL] [Abstract][Full Text] [Related]